Clinical Trial Update: Inflammation and Steatosis: the Role of Alpha-defensin

View source ↗

Summary

A clinical trial investigating the role of alpha-defensin in liver inflammation and fatty liver (steatosis); current status is not reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Non-alcoholic Steatohepatitis

Drugs mentioned

• Alpha-defensin (alpha-defensin)

Snippet

Sponsor: Hillel Yaffe Medical Center | Conditions: Inflammation, Fatty Liver | Status: UNKNOWN